This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Anne Descours - Innovator in Peptide Research
Introduction
Anne Descours is a notable inventor based in Montrouge, France. She has made significant contributions to the field of peptide research, particularly in the development of therapeutic applications for HIV. Her innovative work has led to the creation of a unique peptide sequence that holds promise for medical advancements.
Latest Patents
Anne Descours holds a patent for "CD4 mimic peptides and their uses." This patent describes an isolated peptide comprising a specific sequence that includes thiopropionic acid and various amino acids. The peptide is designed for use in manufacturing anti-HIV therapeutic or vaccine compositions. This groundbreaking work highlights her commitment to addressing critical health challenges.
Career Highlights
Throughout her career, Anne has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant research initiatives.
Collaborations
Anne has collaborated with notable colleagues, including Claudio Vita and Loïc Martin. These partnerships have enriched her research and expanded the impact of her innovations in peptide technology.
Conclusion
Anne Descours is a pioneering inventor whose work in peptide research is making strides in the fight against HIV. Her patent and collaborations reflect her dedication to advancing medical science and improving health outcomes.